UNBELIEVABLE: Ascentage | History Defined

3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead

Inventiva, Larimar Therapeutics, and Ascentage Pharma face key drug-development milestones, with analysts assigning Buy ratings and triple-digit upside price targets to all three biotech stocks.

MarketBeat · 5h ago

3 Small-Cap Stocks With Catalysts That Could Put Them in the Spotlight

Small-cap stocks Ascentage Pharma, Maze Therapeutics, and Pagaya Technologies show improving fundamentals, strong cash positions, and bullish analyst ratings amid shifting investor interest.

MarketBeat · Oct 5